Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zerlinda 4mg/100ml infusion bags
0606020V0BDAAAD
|
Zerlinda | Zoledronic acid | Endocrine System | No data available |
|
Zerolatum Plus bath additive
1302011L0BLAAAD
|
Zerolatum (Light liquid paraffin) | Light liquid paraffin | Skin | No data available |
|
Zerozole bath oil
130201100BBAVAK
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | No data available |
|
Zessly 100mg pdr for concentrate for inf vials
1001030T0BFAAAA
|
Zessly | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Zestril 2.5mg tablets
0205051L0BBAAAA
|
Zestril | Lisinopril | Cardiovascular System | No data available |
|
Zetuvit Plus Superabsorber dressing 20cm x 60cm
20033000549
|
Zetuvit Plus Superabsorber dressing 20cm x 60cm | Wound Management & Other Dressings | Dressings | No data available |
|
Zevona XL 30mg tablets
0206010K0CWAABD
|
Zevona XL | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Ziagen 20mg/ml oral solution
0503010E0BBABAB
|
Ziagen | Abacavir | Infections | No data available |
|
Ziagen 300mg tablets
0503010E0BBAAAA
|
Ziagen | Abacavir | Infections | No data available |
|
Zibor 10,000units/0.4ml inj pre-filled syringes
0208010ACBBAEAE
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 2,500units/0.2ml inj pre-filled syringes (Archimedes)
0208010ACBBABAB
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 2,500units/0.2ml inj pre-filled syringes (ROVI)
0208010ACBBAFAB
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 3,500units/0.2ml inj pre-filled syringes (Archimedes)
0208010ACBBACAC
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 3,500units/0.2ml inj pre-filled syringes (ROVI)
0208010ACBBAGAC
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 5,000units/0.2ml inj pre-filled syringes
0208010ACBBADAD
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Zibor 7,500units/0.3ml inj pre-filled syringes
0208010ACBBAAAA
|
Zibor | Bemiparin sodium | Cardiovascular System | No data available |
|
Ziconotide 100micrograms/1ml solution for infusion vials
1502010X0AAAAAA
|
Ziconotide acetate | Ziconotide acetate | Anaesthesia | No data available |
|
Ziconotide 500micrograms/5ml solution for infusion vials
1502010X0AAABAB
|
Ziconotide acetate | Ziconotide acetate | Anaesthesia | No data available |
|
Zidovudine 10mg/1ml oral solution sugar free
0503010Y0AAADAD
|
Zidovudine | Zidovudine | Infections | No data available |
|
Zidovudine 200mg/20ml solution for infusion vials
0503010Y0AAAEAE
|
Zidovudine | Zidovudine | Infections | No data available |
|
Zidovudine 300mg / Lamivudine 150mg tablets
0503010A0AAAAAA
|
Lamivudine/zidovudine | Lamivudine and zidovudine | Infections | No data available |
|
Ziextenzo 6mg/0.6ml inj pre-filled syringes
0901060P0BEAAAA
|
Ziextenzo | Pegfilgrastim | Nutrition and Blood | No data available |
|
Zildil 90mg modified-release capsules
0206020C0BSABAT
|
Zildil | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Zildil SR 120mg capsules
0206020C0BSACAU
|
Zildil | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Zildil SR 60mg capsules
0206020C0BSAAAJ
|
Zildil | Diltiazem hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.